Skip to main content
. 2015 Jan 23;29(2):258–265. doi: 10.1038/eye.2014.315

Table 1. Details of patients who underwent treatment with yellow laser for central serous chorioretinopathy.

No Age Sex Duration of follow-up (weeks) Focal/diffuse leak CDVA before laser CDVA post laser Lines of improvement OCT fluid height before laser OCT fluid height post laser Reduction Reduction
1 63 M 15 Diffuse 0.301 0.301 0 292 0 292 100%
3 49 M 14 Diffuse 0.176 0.000 1 255 89 166 65%
4 54 M 9 Focal 0.000 0.000 0 359 0 359 100%
5 63 M 11 Focal 0.477 0.477 0 100 10 90 90%
6 27 M 6 Diffuse 0.000 0.000 0 160 0 160 100%
7 40 M 6 Diffuse 0.301 0.000 2 413 0 413 100%
8 48 M 5 Diffuse 0.176 0.176 0 85 36 49 58%
9 42 M 11 Focal 0.176 0.176 0 466 200 266 57%
10 29 M 3 Focal 0.301 0.176 1 139 81 58 42%
11 49 M 7 Focal 1.301 1.000 1 110 0 110 100%
12 49 M 7 Focal 0.301 0.176 1 169 0 169 100%
15 50 M 4 Focal 0.778 0.477 2 340 93 247 73%
16 60 M 5 Focal 0.602 0.602 0 90 80 10 11%
17 60 M 5 Diffuse 0.000 0.000 0 131 70 61 47%
18 50 F 7 Diffuse 0.000 0.000 0 376 84 292 78%
Average 49   8   0.301 0.176 0 232 49.533 182.800 79%